Action Nymox Pharmaceutical (PK) - NYMXF

Nymox Pharmaceutical Corp (PK) (NYMXF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,12

( - )

Prix Achat

0,12

Prix Vente

0,12

Volume échangé

Volume moyen (3 m)

US$ 42 648

Volume financier

0,00 Fourchette du Jour 0,00

0,03 Plage de 52 semaines 0,1999

Cap du marché

12,245M

Valeur d'Entreprise

15,457M

Clôture Veille

0,12

Ouverture

Dernière Transaction

Dernière heure de transaction

VWAP

Chiffre d'affairess (LTM)

Bénéfice net (LTM)

-4,49M

Actions en circulation

102 040 140

Flottant (%)

58,14%

Détention Institutionnelle (%)

0,03%

Rendement du Dividende (LTM)

Ratio Cours sur Bénéfices

-2,5

Ratio Cours/Ventes (P/S)

Bénéfice par action (BPA)

-0,05

Bêta

13,25

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well a... Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low-grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert, a test for determining smoking status; and TobacAlert, a test for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment and prevention of Alzheimer’s disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, Bahamas. Show more

Secteur

Healthcare

Industrie

Biotechnology & Life Sciences

Site Web

nymox.com

Siège social

Nassau, Bahamas

Fondé

1989

Nymox Pharmaceutical Corp (PK) est coté dans le secteur Healthcare de la OTC Markets avec le ticker NYMXF. Le dernier cours de clôture d'Nymox Pharmaceutical (PK) était de US$0,12. Au cours de la dernière année, les actions de Nymox Pharmaceutical (PK) ont été négociées dans une fourchette de prix de US$ 0,03 à US$ 0,1999.

Nymox Pharmaceutical (PK) compte actuellement 102 040 140 actions en circulation. La capitalisation boursière d'Nymox Pharmaceutical (PK) est de US$12,24 million. Nymox Pharmaceutical (PK) a un ratio cours/bénéfice (ratio PE) de -2.50.

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean

IRVINE, CA / ACCESS Newswire / June 17, 2026 / Nymox Pharmaceutical Corporation ("Nymox", "The Company") (OTCQB:NYMXF) is...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0.12	0.1444	0.12	2117	0.12195819	CS
4	0.023	23.7113402062	0.097	0.1495	0.082	40675	0.10577505	CS
12	0.07	140	0.05	0.1999	0.0329	42166	0.08876279	CS
26	0.02565	27.186009539	0.09435	0.1999	0.03	28324	0.08141636	CS
52	0.0003	0.250626566416	0.1197	0.1999	0.03	29745	0.07451653	CS
156	-0.1411	-54.0405974722	0.2611	1.4	0.0001	32958	0.43409136	CS
260	0	0	0.12	1.4	0.0001	33690	0.43376509	CS

NYMXF - Frequently Asked Questions (FAQ)

What is the current Nymox Pharmaceutical Corp (PK) share price?

The current share price of Nymox Pharmaceutical Corp (PK) is US$ 0,12

How many Nymox Pharmaceutical Corp (PK) shares are in issue?

Nymox Pharmaceutical Corp (PK) has 102 040 140 shares in issue

What is the market cap of Nymox Pharmaceutical Corp (PK)?

The market capitalisation of Nymox Pharmaceutical Corp (PK) is USD 12,24M

What is the 1 year trading range for Nymox Pharmaceutical Corp (PK) share price?

Nymox Pharmaceutical Corp (PK) has traded in the range of US$ 0,03 to US$ 0,1999 during the past year

What is the PE ratio of Nymox Pharmaceutical Corp (PK)?

The price to earnings ratio of Nymox Pharmaceutical Corp (PK) is -2,5

What is the registered address of Nymox Pharmaceutical Corp (PK)?

The registered address for Nymox Pharmaceutical Corp (PK) is Bay & Deveaux Streets, Nassau

What is the Nymox Pharmaceutical Corp (PK) website address?

The website address for Nymox Pharmaceutical Corp (PK) is nymox.com

Which industry sector does Nymox Pharmaceutical Corp (PK) operate in?

Nymox Pharmaceutical Corp (PK) operates in the Biotechnology & Life Sciences sector

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Nymox Pharmaceutical Corp (PK) (NYMXF)

Nymox Pharmaceutical Corp (PK) (NYMXF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Nymox Pharmaceutical Corp (PK)

NYMXF Dernières nouvelles

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

NYMOX Provides Current Update

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

NYMOX Provides Recent Updates

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

NYMXF - Frequently Asked Questions (FAQ)

NYMXF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Nymox Pharmaceutical Corp (PK) (NYMXF)

Nymox Pharmaceutical Corp (PK) (NYMXF) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Nymox Pharmaceutical Corp (PK)

NYMXF Dernières nouvelles

Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

NYMOX Provides Current Update

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

NYMOX Provides Recent Updates

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

NYMXF - Frequently Asked Questions (FAQ)

NYMXF Transactions

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités